Transcription regulates HIF-1α expression in CD4(+) T cells.
Identifieur interne : 000972 ( Main/Exploration ); précédent : 000971; suivant : 000973Transcription regulates HIF-1α expression in CD4(+) T cells.
Auteurs : Thomas Bollinger [Suisse, Allemagne] ; Annalena Bollinger [Suisse] ; Sydney Gies [Allemagne] ; Lea Feldhoff [Allemagne] ; Werner Solbach [Allemagne] ; Jan Rupp [Allemagne]Source :
- Immunology and cell biology [ 1440-1711 ] ; 2016.
Descripteurs français
- KwdFr :
- ARN messager (génétique), ARN messager (métabolisme), Activation des lymphocytes (immunologie), Femelle (MeSH), Humains (MeSH), Lymphocytes T CD4+ (immunologie), Lymphocytes T CD4+ (métabolisme), Mâle (MeSH), Régulation de l'expression des gènes (MeSH), Sous-unité alpha du facteur-1 induit par l'hypoxie (génétique), Sous-unité alpha du facteur-1 induit par l'hypoxie (métabolisme), Stabilité protéique (MeSH), Transcription génétique (MeSH).
- MESH :
- génétique : ARN messager, Sous-unité alpha du facteur-1 induit par l'hypoxie.
- immunologie : Activation des lymphocytes, Lymphocytes T CD4+.
- métabolisme : ARN messager, Lymphocytes T CD4+, Sous-unité alpha du facteur-1 induit par l'hypoxie.
- Femelle, Humains, Mâle, Régulation de l'expression des gènes, Stabilité protéique, Transcription génétique.
English descriptors
- KwdEn :
- CD4-Positive T-Lymphocytes (immunology), CD4-Positive T-Lymphocytes (metabolism), Female (MeSH), Gene Expression Regulation (MeSH), Humans (MeSH), Hypoxia-Inducible Factor 1, alpha Subunit (genetics), Hypoxia-Inducible Factor 1, alpha Subunit (metabolism), Lymphocyte Activation (immunology), Male (MeSH), Protein Stability (MeSH), RNA, Messenger (genetics), RNA, Messenger (metabolism), Transcription, Genetic (MeSH).
- MESH :
- chemical , genetics : Hypoxia-Inducible Factor 1, alpha Subunit, RNA, Messenger.
- immunology : CD4-Positive T-Lymphocytes, Lymphocyte Activation.
- metabolism : CD4-Positive T-Lymphocytes, Hypoxia-Inducible Factor 1, alpha Subunit, RNA, Messenger.
- Female, Gene Expression Regulation, Humans, Male, Protein Stability, Transcription, Genetic.
Abstract
The transcription factor hypoxia inducible factor-1α (HIF-1α) mediates the metabolic adaptation of cells to hypoxia and T-helper cell fate. However, HIF-1α regulation in CD4(+) T cells (T cells) remains elusive. Here we observed that depletion of oxygen (O2⩽2%) alone was not sufficient to induce HIF-1α expression in T cells. However, when hypoxic T cells were stimulated, HIF-1α was expressed and this was dependent on nuclear factor-κB- and nuclear factor of activated T cell (NFAT)-mediated transcriptional upregulation of Hif-1α mRNA. HIF-1α upregulation could be blocked by drugs inhibiting NF-κB, NFAT or mammalian target of rapamycin precluding CD4(+) T-cell stimulation or translation in T cells, as well as by blocking transcription. CD3, CD28, phorbol-12-myristat-13-acetat (PMA) or ionomycin-stimulated T cells did not express HIF-1α under normoxic conditions. In conclusion, regulation of HIF-1α expression in CD4(+) T cells in hypoxia gravely relies on its transcriptional upregulation and subsequent enhanced protein stabilization.
DOI: 10.1038/icb.2015.64
PubMed: 26150319
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Transcription regulates HIF-1α expression in CD4(+) T cells.</title>
<author><name sortKey="Bollinger, Thomas" sort="Bollinger, Thomas" uniqKey="Bollinger T" first="Thomas" last="Bollinger">Thomas Bollinger</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Molecular Biology, Sciences III, University of Geneva, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Molecular Biology, Sciences III, University of Geneva, Geneva</wicri:regionArea>
<orgName type="university">Université de Genève</orgName>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bollinger, Annalena" sort="Bollinger, Annalena" uniqKey="Bollinger A" first="Annalena" last="Bollinger">Annalena Bollinger</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Immunology and Allergy, Department of Medical Specialties, University Hospital and Medical Faculty, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Division of Immunology and Allergy, Department of Medical Specialties, University Hospital and Medical Faculty, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gies, Sydney" sort="Gies, Sydney" uniqKey="Gies S" first="Sydney" last="Gies">Sydney Gies</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Feldhoff, Lea" sort="Feldhoff, Lea" uniqKey="Feldhoff L" first="Lea" last="Feldhoff">Lea Feldhoff</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Solbach, Werner" sort="Solbach, Werner" uniqKey="Solbach W" first="Werner" last="Solbach">Werner Solbach</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rupp, Jan" sort="Rupp, Jan" uniqKey="Rupp J" first="Jan" last="Rupp">Jan Rupp</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26150319</idno>
<idno type="pmid">26150319</idno>
<idno type="doi">10.1038/icb.2015.64</idno>
<idno type="wicri:Area/Main/Corpus">000C29</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C29</idno>
<idno type="wicri:Area/Main/Curation">000C29</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C29</idno>
<idno type="wicri:Area/Main/Exploration">000C29</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Transcription regulates HIF-1α expression in CD4(+) T cells.</title>
<author><name sortKey="Bollinger, Thomas" sort="Bollinger, Thomas" uniqKey="Bollinger T" first="Thomas" last="Bollinger">Thomas Bollinger</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Molecular Biology, Sciences III, University of Geneva, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Molecular Biology, Sciences III, University of Geneva, Geneva</wicri:regionArea>
<orgName type="university">Université de Genève</orgName>
<placeName><settlement type="city">Genève</settlement>
<region nuts="3" type="region">Canton de Genève</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bollinger, Annalena" sort="Bollinger, Annalena" uniqKey="Bollinger A" first="Annalena" last="Bollinger">Annalena Bollinger</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Immunology and Allergy, Department of Medical Specialties, University Hospital and Medical Faculty, Geneva, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Division of Immunology and Allergy, Department of Medical Specialties, University Hospital and Medical Faculty, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gies, Sydney" sort="Gies, Sydney" uniqKey="Gies S" first="Sydney" last="Gies">Sydney Gies</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Feldhoff, Lea" sort="Feldhoff, Lea" uniqKey="Feldhoff L" first="Lea" last="Feldhoff">Lea Feldhoff</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Solbach, Werner" sort="Solbach, Werner" uniqKey="Solbach W" first="Werner" last="Solbach">Werner Solbach</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rupp, Jan" sort="Rupp, Jan" uniqKey="Rupp J" first="Jan" last="Rupp">Jan Rupp</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck</wicri:regionArea>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
<wicri:noRegion>Lübeck</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Immunology and cell biology</title>
<idno type="eISSN">1440-1711</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>CD4-Positive T-Lymphocytes (metabolism)</term>
<term>Female (MeSH)</term>
<term>Gene Expression Regulation (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hypoxia-Inducible Factor 1, alpha Subunit (genetics)</term>
<term>Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)</term>
<term>Lymphocyte Activation (immunology)</term>
<term>Male (MeSH)</term>
<term>Protein Stability (MeSH)</term>
<term>RNA, Messenger (genetics)</term>
<term>RNA, Messenger (metabolism)</term>
<term>Transcription, Genetic (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>ARN messager (génétique)</term>
<term>ARN messager (métabolisme)</term>
<term>Activation des lymphocytes (immunologie)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Lymphocytes T CD4+ (métabolisme)</term>
<term>Mâle (MeSH)</term>
<term>Régulation de l'expression des gènes (MeSH)</term>
<term>Sous-unité alpha du facteur-1 induit par l'hypoxie (génétique)</term>
<term>Sous-unité alpha du facteur-1 induit par l'hypoxie (métabolisme)</term>
<term>Stabilité protéique (MeSH)</term>
<term>Transcription génétique (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Hypoxia-Inducible Factor 1, alpha Subunit</term>
<term>RNA, Messenger</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>ARN messager</term>
<term>Sous-unité alpha du facteur-1 induit par l'hypoxie</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Activation des lymphocytes</term>
<term>Lymphocytes T CD4+</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
<term>Lymphocyte Activation</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term>
<term>Hypoxia-Inducible Factor 1, alpha Subunit</term>
<term>RNA, Messenger</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>ARN messager</term>
<term>Lymphocytes T CD4+</term>
<term>Sous-unité alpha du facteur-1 induit par l'hypoxie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Gene Expression Regulation</term>
<term>Humans</term>
<term>Male</term>
<term>Protein Stability</term>
<term>Transcription, Genetic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Régulation de l'expression des gènes</term>
<term>Stabilité protéique</term>
<term>Transcription génétique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The transcription factor hypoxia inducible factor-1α (HIF-1α) mediates the metabolic adaptation of cells to hypoxia and T-helper cell fate. However, HIF-1α regulation in CD4(+) T cells (T cells) remains elusive. Here we observed that depletion of oxygen (O2⩽2%) alone was not sufficient to induce HIF-1α expression in T cells. However, when hypoxic T cells were stimulated, HIF-1α was expressed and this was dependent on nuclear factor-κB- and nuclear factor of activated T cell (NFAT)-mediated transcriptional upregulation of Hif-1α mRNA. HIF-1α upregulation could be blocked by drugs inhibiting NF-κB, NFAT or mammalian target of rapamycin precluding CD4(+) T-cell stimulation or translation in T cells, as well as by blocking transcription. CD3, CD28, phorbol-12-myristat-13-acetat (PMA) or ionomycin-stimulated T cells did not express HIF-1α under normoxic conditions. In conclusion, regulation of HIF-1α expression in CD4(+) T cells in hypoxia gravely relies on its transcriptional upregulation and subsequent enhanced protein stabilization.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26150319</PMID>
<DateCompleted><Year>2016</Year>
<Month>09</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1440-1711</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>94</Volume>
<Issue>1</Issue>
<PubDate><Year>2016</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Immunology and cell biology</Title>
<ISOAbbreviation>Immunol Cell Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Transcription regulates HIF-1α expression in CD4(+) T cells.</ArticleTitle>
<Pagination><MedlinePgn>109-13</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/icb.2015.64</ELocationID>
<Abstract><AbstractText>The transcription factor hypoxia inducible factor-1α (HIF-1α) mediates the metabolic adaptation of cells to hypoxia and T-helper cell fate. However, HIF-1α regulation in CD4(+) T cells (T cells) remains elusive. Here we observed that depletion of oxygen (O2⩽2%) alone was not sufficient to induce HIF-1α expression in T cells. However, when hypoxic T cells were stimulated, HIF-1α was expressed and this was dependent on nuclear factor-κB- and nuclear factor of activated T cell (NFAT)-mediated transcriptional upregulation of Hif-1α mRNA. HIF-1α upregulation could be blocked by drugs inhibiting NF-κB, NFAT or mammalian target of rapamycin precluding CD4(+) T-cell stimulation or translation in T cells, as well as by blocking transcription. CD3, CD28, phorbol-12-myristat-13-acetat (PMA) or ionomycin-stimulated T cells did not express HIF-1α under normoxic conditions. In conclusion, regulation of HIF-1α expression in CD4(+) T cells in hypoxia gravely relies on its transcriptional upregulation and subsequent enhanced protein stabilization.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bollinger</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Department of Molecular Biology, Sciences III, University of Geneva, Geneva, Switzerland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bollinger</LastName>
<ForeName>Annalena</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Division of Immunology and Allergy, Department of Medical Specialties, University Hospital and Medical Faculty, Geneva, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gies</LastName>
<ForeName>Sydney</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Feldhoff</LastName>
<ForeName>Lea</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Solbach</LastName>
<ForeName>Werner</ForeName>
<Initials>W</Initials>
<AffiliationInfo><Affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rupp</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Medical Microbiology and Hygiene, University of Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Molecular and Clinical Infectious Diseases, University of Lübeck, Lübeck, Germany.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>07</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Immunol Cell Biol</MedlineTA>
<NlmUniqueID>8706300</NlmUniqueID>
<ISSNLinking>0818-9641</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D051795">Hypoxia-Inducible Factor 1, alpha Subunit</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051795" MajorTopicYN="N">Hypoxia-Inducible Factor 1, alpha Subunit</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008213" MajorTopicYN="N">Lymphocyte Activation</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055550" MajorTopicYN="N">Protein Stability</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014158" MajorTopicYN="Y">Transcription, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>05</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>06</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>10</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26150319</ArticleId>
<ArticleId IdType="pii">icb201564</ArticleId>
<ArticleId IdType="doi">10.1038/icb.2015.64</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Immunol. 2008 Aug 1;181(3):1665-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18641302</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 May 18;101(20):7554-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15131267</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18154-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17114296</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2011 Jan 15;186(2):1091-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21149600</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Microbiol. 2007 Sep;9(9):2181-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17490410</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Physiol. 1998 Oct;275(4 Pt 1):L818-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9755115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Biol. 2008 Jan;28(1):93-107</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17967866</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Pharm Des. 2009;15(33):3853-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19671045</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2011;6(12):e29801</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22216357</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2012 Oct;13(10):907-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22990888</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2011 Jun 9;117(23):e207-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21447827</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Biol Cell. 2007 Dec;18(12 ):4691-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17898080</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Free Radic Biol Med. 2011 Aug 1;51(3):700-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21664270</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):755-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17272744</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell Biol. 2002 Oct;22(20):7004-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12242281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2006 Jun 15;396(3):517-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16533170</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2014 Oct 16;41(4):518-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25367569</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2011 Jul 4;208(7):1367-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21708926</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbes Infect. 2012 Apr;14(4):311-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22133978</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Cancer. 2008 Sep;8(9):705-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19143055</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FASEB J. 2003 Nov;17 (14 ):2115-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12958148</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2013 Nov;14 (11):1173-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24076634</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Prolif. 2005 Aug;38(4):257-67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16098184</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2008 Jun 5;453(7196):807-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18432192</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Leukoc Biol. 2014 Aug;96(2):305-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24664971</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell. 2011 Sep 2;146(5):772-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21871655</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2003 Dec 15;171(12):6534-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14662854</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2007 Jul 13;282(28):20534-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17502379</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Pharmacol. 2006 Nov;70(5):1469-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16887934</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2008 Jun 15;412(3):e17-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18498249</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem J. 2008 Jun 15;412(3):477-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18393939</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2001 Dec 1;167(11):6140-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11714773</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
<li>Suisse</li>
</country>
<region><li>Canton de Genève</li>
</region>
<settlement><li>Genève</li>
</settlement>
<orgName><li>Université de Genève</li>
</orgName>
</list>
<tree><country name="Suisse"><region name="Canton de Genève"><name sortKey="Bollinger, Thomas" sort="Bollinger, Thomas" uniqKey="Bollinger T" first="Thomas" last="Bollinger">Thomas Bollinger</name>
</region>
<name sortKey="Bollinger, Annalena" sort="Bollinger, Annalena" uniqKey="Bollinger A" first="Annalena" last="Bollinger">Annalena Bollinger</name>
</country>
<country name="Allemagne"><noRegion><name sortKey="Bollinger, Thomas" sort="Bollinger, Thomas" uniqKey="Bollinger T" first="Thomas" last="Bollinger">Thomas Bollinger</name>
</noRegion>
<name sortKey="Feldhoff, Lea" sort="Feldhoff, Lea" uniqKey="Feldhoff L" first="Lea" last="Feldhoff">Lea Feldhoff</name>
<name sortKey="Feldhoff, Lea" sort="Feldhoff, Lea" uniqKey="Feldhoff L" first="Lea" last="Feldhoff">Lea Feldhoff</name>
<name sortKey="Gies, Sydney" sort="Gies, Sydney" uniqKey="Gies S" first="Sydney" last="Gies">Sydney Gies</name>
<name sortKey="Gies, Sydney" sort="Gies, Sydney" uniqKey="Gies S" first="Sydney" last="Gies">Sydney Gies</name>
<name sortKey="Rupp, Jan" sort="Rupp, Jan" uniqKey="Rupp J" first="Jan" last="Rupp">Jan Rupp</name>
<name sortKey="Rupp, Jan" sort="Rupp, Jan" uniqKey="Rupp J" first="Jan" last="Rupp">Jan Rupp</name>
<name sortKey="Solbach, Werner" sort="Solbach, Werner" uniqKey="Solbach W" first="Werner" last="Solbach">Werner Solbach</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000972 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000972 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= RapamycinFungusV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:26150319 |texte= Transcription regulates HIF-1α expression in CD4(+) T cells. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26150319" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a RapamycinFungusV1
This area was generated with Dilib version V0.6.38. |